Brokerages remain divided on Dabur after its Q1 FY27 business update, with Nomura maintaining a Buy, Macquarie staying Neutral and Morgan Stanley retaining an Underweight rating.
Can Dabur's Strong Q1 Performance Justify the Bullish Brokerage Outlook?
Dabur India has reported an encouraging business update for the first quarter of FY27, indicating a return to double-digit consolidated revenue growth after nearly three years. Stable operating margins, improving profitability and a recovery across several business segments have attracted positive commentary from leading brokerages, although opinions remain divided on the stock's valuation and future growth potential.
Brokerage View
Nomura
✅ Buy | Target Price: ₹600
• Double-digit consolidated sales growth after 11 quarters.
• PAT also expected to grow at double-digit levels.
• Strong performance from Home & Personal Care and Foods.
• International business showing a meaningful recovery.
• Valuation considered attractive versus long-term averages.
Macquarie
✅ Neutral | Target Price: ₹470
• Domestic business broadly in line with expectations.
• International business performed better than expected.
• Margins remained stable.
• Concern remains over rural demand if adverse weather impacts consumption.
Morgan Stanley
✅ Underweight | Target Price: ₹425
• Revenue and PAT expected to record double-digit growth.
• Rural demand continues to outperform urban markets.
• International revenue expected to grow in high teens.
• Management remains optimistic on domestic and overseas demand.
Stay updated with quality research-backed market insights through our latest Nifty Tip from Indian-Share-Tips.com.
Q1 FY27 Business Snapshot
| Business Indicator |
Trend |
| Consolidated Revenue |
Double-digit growth |
| PAT |
Double-digit growth expected |
| Operating Margin |
Stable |
| Home & Personal Care |
Strong growth |
| Foods & International |
Strong recovery |
Key Opportunities & Risks
🔹 Demand recovery is visible across several product categories.
🔹 International operations are showing improving momentum.
🔹 Stable margins strengthen earnings visibility.
🔹 Rural demand, weather conditions and raw material inflation remain important variables to monitor.
Dabur remains one of India's leading FMCG companies with a diversified portfolio across healthcare, personal care, foods and beverages. The company's improving international business, continued rural demand and stable profitability provide a constructive operating backdrop, although differing brokerage opinions indicate that valuation remains an important consideration for investors.
For professional derivatives market insights, explore the latest BankNifty Tip on Indian-Share-Tips.com.
Investor Takeaway
Derivative Pro & Nifty Expert Gulshan Khera, CFP®, observes that Dabur's Q1 business update indicates improving operational momentum with healthy revenue growth and stable margins. While most brokerages acknowledge stronger fundamentals, their target prices differ primarily because of valuation assumptions and future demand expectations. Investors should evaluate earnings growth, rural consumption trends, international performance and valuations together before making investment decisions.
Related Queries
• Why are brokerages divided on Dabur?
• What drove Dabur's Q1 FY27 growth?
• Is Dabur's international business recovering?
• How important is rural demand for Dabur?
• Is Dabur attractive after the latest business update?
Disclaimer: Brokerage recommendations represent the opinions of individual research firms and may differ significantly. This article is intended for educational purposes only and should not be construed as investment advice.
Dabur India,Nomura,Macquarie,Morgan Stanley,FMCG Stocks,Q1 FY27,Brokerage Report,Target Price,Rural Demand,Indian Share Tips